IMANX Mutual Fund

IMANX Mutual Fund

NAV$22.45
See how much of IMANX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of May 31, 2026

Net Assets
$270M
Expense Ratio
1.00%
Dividend Yield (Current)
0.11%
Holdings
118
Inception Date
Jun 30, 2000
Fund Family
Allied Asset Advisors
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+16.09%
1 Year+29.94%
3 Year+19.09%
5 Year+9.83%
10 Year+13.35%

Asset Allocation

Stocks: 100.00%
See how much of IMANX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AAPLApple, Inc8.01%
NVDANvidia Corp.6.51%
GOOGAlphabet Inc. C5.74%
TSM:TWTaiwan Semiconductor - Adr5.35%
MSFTMicrosoft Corp5.29%
Top 10 Concentration: 47.30%Report Date: May 31, 2026
Download all 118 holdings for IMANX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.11%
Frequency
Annually
Latest Distribution
$3.01
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

IMANX Mutual Fund Overview

IMANX Mutual Fund (Iman Fund Class K) is managed by Allied Asset Advisors with $270.3M in net assets. IMANX expense ratio is 1.00%, holding 118 positions across sectors including Information Technology, Health Care, Communication Services. Inception date: 2000-06-30.

IMANX performance shows a YTD return of 16.09%. The 1-year return is 29.94% and the 5-year return is 9.83%. IMANX dividend yield stands at 0.11%, paid annually.

IMANX top holdings include Apple, Inc (8.0%), Nvidia Corp. (6.5%), Alphabet Inc. C (5.7%), Taiwan Semiconductor - Adr (5.3%), Microsoft Corp (5.3%). Go to all IMANX holdings, IMANX sectors, or IMANX dividends.

IMANX can be compared against other funds. Use IMANX overlap to find shared positions, or IMANX vs another fund for a side-by-side view. IMANX alternatives are available via the screener, along with tax-loss harvesting opportunities.